These data suggest the hypothesis that reduced carnitine palmitoyltransferase-I (CPT-I) activity and mitochondrial fatty acid transport may contribute to the pathogenesis of ME/CFS and GWI, and that appropriate nutrient supplementation may correct the imbalances. The gene discussed is CPT1C; the disease is myalgic encephalomeyelitis/chronic fatigue syndrome.